Основная статистика
| CIK | 1555995 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Bioscience Neutraceuticals Inc
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
| March 30, 2020 |
10-K 1 devv10k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-3 |
|
| November 12, 2019 |
DEVV / Bioscience Neutraceuticals, Inc. 10-Q - Quarterly Report - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36604 BIOSCIENCE N |
|
| August 12, 2019 |
DEVV / Bioscience Neutraceuticals, Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36604 BIOSCIENCE NEUTRA |
|
| May 15, 2019 |
DEVV / Bioscience Neutraceuticals, Inc. 10-Q Quarterly Report FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2019 or ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36604 BIOSCIENCE NEU |
|
| April 22, 2019 |
Unregistered Sales of Equity Securities 8-K 1 devv8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 21, 2019 BIOSCIENCE NEUTRACEUTICALS, INC. (Exact name of registrant as specified in its charter) Nevada 001-36604 46-0745348 (State or other jurisdictio |
|
| April 9, 2019 |
DEVV / Bioscience Neutraceuticals, Inc. FORM 10-K (Annual Report) 10-K 1 devv10k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file numb |
|
| April 1, 2019 |
DEVV / Bioscience Neutraceuticals, Inc. NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D o Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2018 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition |
|
| February 7, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 7, 2019 BIOSCIENCE NEUTRACEUTICALS, INC. (Exact name of registrant as specified in its charter) Nevada 001-36604 46-0745348 (State or other jurisdiction of incorporation) (Com |
|
| January 18, 2019 |
DEVV / Bioscience Neutraceuticals, Inc. DEF 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ¨ Preliminary Information Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) x Definitive Information Statement Bioscience Neutraceuticals, Inc. |
|
| January 9, 2019 |
DEVV / Bioscience Neutraceuticals, Inc. FORM 10-Q (Quarterly Report) 10-Q 1 devv10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 or ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File |
|
| January 3, 2019 |
JBCT / Joblocationmap Incorporated PRE 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ¨ Definitive Information Statement Bioscience Neutraceuticals Inc. |
|
| December 11, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 12, 2018 BIOSCIENCE NEUTRACEUTICALS, INC. (Exact name of registrant as specified in its charter) Nevada 001-36604 46-0745348 (State or other jurisdiction of incorporation) (Co |
|
| December 11, 2018 |
EX-3 2 jbctex31.htm EXHIBIT 3.1 EXHIBIT 3.1 |
|
| November 19, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2018 JOBLOCATIONMAP, INC. (Exact name of registrant as specified in its charter) Nevada 001-36604 46-0745348 (State or other jurisdiction of incorporation) (Commission Fi |
|
| November 14, 2018 |
JBCT / Joblocationmap Incorporated NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D o Form N-SAR ¨ Form N-CSR For Period Ended: September 30, 2018 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition |
|
| November 8, 2018 |
JBCT / Joblocationmap Incorporated FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 or ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36604 JobLocationMap In |
|
| May 14, 2018 |
JBCT / Joblocationmap Incorporated FORM 10-Q (Quarterly Report) 10-Q 1 jbct10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 or ¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numb |
|
| April 12, 2018 |
JBCT / Joblocationmap Incorporated FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number 001-36604 JOBLOCATIONMAP I |
|
| April 3, 2018 |
JBCT / Joblocationmap Incorporated NT 10-K NT 10-K 1 jbctnt10k.htm NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D o Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2017 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition R |
|
| December 7, 2017 |
JBCT / Joblocationmap Incorporated FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 or o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36604 JobLocationM |
|
| December 5, 2017 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant jbct8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 30, 2017 JOBLOCATIONMAP INC. (Exact name of registrant as specified in its charter) Nevada 001-36604 46-0745348 (State or other jurisdiction of incorporation) (Comm |
|
| December 5, 2017 |
Letter from Michael Gillespie & Associates, PLLC doc1.htm Exhibit 16.1 MICHAEL GILLESPIE & ASSOCIATES, PLLC CERTIFIED PUBLIC ACCOUNTANTS 10544 ALTON AVE NE SEATTLE, WA 98125 206.353.5736 Exhibit 16.1 December 4, 2017 Office of the Chief Accountant Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: JOBLOCATIONMAP INC. Dear Sirs/Madams: The undersigned Michael Gillespie & Associates, PLLC previously acted as independe |
|
| November 9, 2017 |
Bio Health Products Inc. F/K/A Essential Oils jbctex992.htm EXHIBIT99.2 Bio Health Products Inc. F/K/A Essential Oils INDEX TO FINANCIAL STATEMENTS June 30, 2017 (Unaudited) Page Balance Sheets 1 Statements of Operations 2 Statements of Cash Flows 3 Notes to the Financial Statements 4 1 Bio Health Products Inc. F/K/A Essential Oils Balance Sheets June 30, December 31, 2017 2016 ASSETS Current Assets Cash and cash equivalents $ 83 $ 6,015 Inve |
|
| November 9, 2017 |
Change in Shell Company Status, Completion of Acquisition or Disposition of Assets 8-K 1 jbct8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 10, 2017 JOBLOCATIONMAP INC. (Exact name of registrant as specified in its charter) Nevada 001-36604 46-0745348 (State or Other Jurisdiction (Commission |
|
| November 9, 2017 |
jbctex993.htm EXHIBIT 99.3 JOBLOCATION MAP INC. Supplemental Information Unaudited Pro Forma Consolidated Balance Sheets June 30, 2017 The following statements represent pro forma disclosures applicable to the share purchase agreement with Bio Health Products Inc. The unaudited pro forma condensed balance sheet as of June 30, 2017, is based on the balance sheets of Joblocationmap Inc. and Bio Heal |
|
| November 9, 2017 |
AGREEMENT FOR THE EXCHANGE OF STOCK jbctex994.htm EXHIBIT 99.4 THE SECURITIES WHICH ARE THE SUBJECT OF THIS AGREEMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "1933 ACT"), NOR REGISTERED UNDER ANY STATE SECURITIES LAW, AND ARE "RESTRICTED SECURITIES" AS THAT TERM IS DEFINED IN RULE 144 UNDER THE 1933 ACT. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD OR OTHERWISE TRANSFERRED, EXCEPT PURSUANT TO AN EFFECTIVE |
|
| November 9, 2017 |
Bio Health Products Inc. F/K/A Essential Oils jbctex991.htm EXHIBIT 99.1 Bio Health Products Inc. F/K/A Essential Oils INDEX TO FINANCIAL STATEMENTS Inception to December 31, 2016 and December 31, 2015 Page Report of Independent Registered Public Accounting Firm 2 Balance Sheets 3 Statements of Operations 4 Statements of Owners? Capital 5 Statements of Cash Flows 6 Notes to the Financial Statements 7 1 REPORT OF INDEPENDENT REGISTERED PUBLIC |
|
| October 11, 2017 |
JBCT / Joblocationmap Incorporated FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 or o TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36604 JobLocationMap In |
|
| May 22, 2017 |
Joblocationmap QUARTERLY REPORT (Quarterly Report) Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 Or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36604 JobLocationMap Inc. |
|
| May 17, 2017 |
AGREEMENT FOR THE PURCHASE OF COMMON STOCK EX-99.1 2 jbctex99z1.htm AGREEMENT FOR THE PURCHASE OF COMMON STOCK EXHIBIT 99.1 AGREEMENT FOR THE PURCHASE OF COMMON STOCK THIS COMMON STOCK PURCHASE AGREEMENT, (this “Agreement”) made this day of April, 2017, by and between Mr. Omri Morchi and Ms. Eden Shoua (hereinafter referred to as (“Sellers”), and (“Purchaser”), setting forth the terms and conditions upon which the Sellers will sell a total |
|
| May 17, 2017 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2017 JOBLOCATIONMAP INC. (Exact name of registrant as specified in its charter) Nevada 001-36604 46-0745348 (State or Other Jurisdiction (Commission (I.R.S. E |
|
| May 15, 2017 |
Joblocationmap NOTIFICATION OF LATE FILING Notification of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 15, 2017 |
Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2017 JOBLOCATIONMAP INC. (Exact name of registrant as specified in its charter) Nevada 001-36604 46-0745348 (State or Other Jurisdiction (Commission (I.R.S. Empl |
|
| May 15, 2017 |
Weinberg & Baer LLC 115 Sudbrook Lane, Baltimore, MD 21208 Phone (410) 702-5660 Auditor Letter EXHIBIT 16.1 Weinberg & Baer LLC 115 Sudbrook Lane, Baltimore, MD 21208 Phone (410) 702-5660 May 11, 2017 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read Item 4.01 of Joblocationmap, Inc. Form 8-K dated May 11, 2017, and are in agreement with the statements relating to Weinberg & Baer LLC contained therein. We have no basis to a |
|
| May 1, 2017 |
SC 14F1 1 jbct-2017050114f.htm JOBLOCATIONMAP United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 - INFORMATION STATEMENT PURSUANT TO SECTION 14(f) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 14f-1 THEREUNDER - JOBLOCATIONMAP INC. - (Name of Registrant) Nevada 001-36604 46-0745348 (State of Incorporation) (Commission File No.) (IRS Employer Identification No.) 153 West Lake |
|
| March 31, 2017 |
Joblocationmap JOBLOCATIONMAP, INC., 10-K (Annual Report) U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-K [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For fiscal year ended: December 31, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-185046 JobLocationMap (Name of Registrant in |
|
| November 10, 2016 |
Joblocationmap JOBLOCATIONMAP, INC., 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 333-188225 |
|
| August 11, 2016 |
Joblocationmap JOBLOCATIONMAP INC, 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 333-188225 JobLo |
|
| May 11, 2016 |
Joblocationmap JOBLOCAITONMAP INC, 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 333-188225 JobL |
|
| April 8, 2016 |
Joblocationmap JOBLOCATIONMAP, 10-K/A (Annual Report) U.S. Securities and Exchange Commission Washington, D.C. 20549 Amendment No. 1 to Form 10-K [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For fiscal year ended: December 31, 2015 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-185046 JOBLOCATIONMAP INC |
|
| March 28, 2016 |
Joblocationmap JOBLOCATIONMAP, 10-K (Annual Report) U.S. Securities and Exchange Commission Washington, D.C. 20549 Form 10-K [x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For fiscal year ended: December 31, 2015 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-185046 JobLocationMap (Name of Registrant in |
|
| November 23, 2015 |
PRIVATE PLACEMENT SUBSCRIPTION AGREEMENT JobLocationMap, Inc. I acknowledge that the Company does not make any representation or warranty concerning the completeness of any information provided. I also acknowledge and agree that I have been advised to conduct my own review of the business and affairs of the Company before subscribing. 1. INVESTMENT: (a) The undersigned subscribes for 4,000,000 sha |
|
| November 23, 2015 |
PRIVATE PLACEMENT SUBSCRIPTION AGREEMENT JobLocationMap, Inc. I acknowledge that the Company does not make any representation or warranty concerning the completeness of any information provided. I also acknowledge and agree that I have been advised to conduct my own review of the business and affairs of the Company before subscribing. 1. INVESTMENT: (a) The undersigned subscribes for 4,000,000 sha |
|
| November 23, 2015 |
DEVV / Bioscience Neutraceuticals, Inc. / Eden Shoua - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D /A Under the Securities Exchange Act of 1934 (Amendment No. ) JOBLOCATIONMAP, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $.001 PER SHARE (Title of Class of Securities) 47770W 108 (CUSIP Number) Eden Shua 5348 Vegas Drive. #407 Las Vegas, NV 89108 702- 586-1338 (Name, Address and Telephone Number of Person Autho |
|
| November 23, 2015 |
Joblocationmap SC 13D/A - OMRI (Activist Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. ) JOBLOCATIONMAP, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $.001 PER SHARE (Title of Class of Securities) 47770W 108 (CUSIP Number) Omri Morchi 5348 Vegas Drive. #407 Las Vegas, NV 89108 702- 586-1338 (Name, Address and Telephone Number of Person Auth |
|
| November 19, 2015 |
DEVV / Bioscience Neutraceuticals, Inc. / Omri Morchi - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) JOBLOCATIONMAP, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $.001 PER SHARE (Title of Class of Securities) 47770W 108 (CUSIP Number) Omri Morchi 5348 Vegas Drive. #407 Las Vegas, NV 89108 702- 586-1338 (Name, Address and Telephone Number of Person Author |
|
| November 19, 2015 |
PRIVATE PLACEMENT SUBSCRIPTION AGREEMENT JobLocationMap, Inc. I acknowledge that the Company does not make any representation or warranty concerning the completeness of any information provided. I also acknowledge and agree that I have been advised to conduct my own review of the business and affairs of the Company before subscribing. 1. INVESTMENT: (a) The undersigned subscribes for 4,000,000 sha |
|
| November 18, 2015 |
DEVV / Bioscience Neutraceuticals, Inc. / Eden Shoua - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) JOBLOCATIONMAP, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $.001 PER SHARE (Title of Class of Securities) 47770W 108 (CUSIP Number) Eden Shua 5348 Vegas Drive. #407 Las Vegas, NV 89108 702- 586-1338 (Name, Address and Telephone Number of Person Authoriz |
|
| November 9, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 JOBLOCATIONMAP, INC. (Exact name of registrant as specified in its charter) Nevada 46-0745348 (State of Incorporation or organization) (IRS Employer Identification No.) 153 W. Lake Mead Pkwy., Ste. |
|
| August 21, 2014 |
DEVV / Bioscience Neutraceuticals, Inc. 8-A12B - - JOBLOCATION MAP, INC., 8-A12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 JOBLOCATIONMAP, INC. (Exact name of registrant as specified in its charter) Nevada 46-0745348 (State of Incorporation or organization) (IRS Employer Identification No.) 153 W. Lake Mead Pkwy., Ste. |
|
| May 13, 2014 |
May 13, 2014 Maryse Mills-Apenteng Special Counsel Barbara C. Jacobs Assistant Director United States Securities and Exchange Commission Washington, D.C. 20549 Re: JobLocationMap Inc. Registration Statement on Form S-1 File No. 333-188225 RE: Request for Accelerated Effectiveness of Registration Dear Ms. Mills-Apenteng: JobLocationMap, Inc. hereby requests that its registration statement on Form S |
|
| May 6, 2014 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1/ A8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 JobLocationMap (Exact name of Registrant as specified in its charter) Nevada 8999 46-0745348 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 153 W. Lake Mead Pkw |
|
| April 17, 2014 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1/A7 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 JobLocationMap (Exact name of Registrant as specified in its charter) Nevada 8999 46-0745348 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 153 W. Lake Mead Pkwy |
|
| April 17, 2014 |
April 15, 2014 Maryse Mills-Apenteng Special Counsel Barbara C. Jacobs Assistant Director United States Securities and Exchange Commission Washington, D.C. 20549 Re: JobLocationMap Inc. Amendment No. 6 to Registration Statement on Form S-1 File No. 333-188225 Filed December 5, 2013 Dear Ms. Mills-Apenteng: Below please find the Company’s responses to your oral comments. General 1. Please clarify t |
|
| March 21, 2014 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1/A6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 JobLocationMap (Exact name of Registrant as specified in its charter) Nevada 8999 46-0745348 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 153 W. Lake Mead Pkwy |
|
| January 8, 2014 |
January 6, 2014 Maryse Mills-Apenteng Special Counsel Barbara C. Jacobs Assistant Director United States Securities and Exchange Commission Washington, D.C. 20549 Re: JobLocationMap Inc. Amendment No. 4 to Registration Statement on Form S-1 File No. 333-188225 Filed December 5, 2013 Dear Ms. Mills-Apenteng: Below please find the Company’s responses to your comment letter of December 23, 2013. Gene |
|
| January 8, 2014 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1/A5 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 JobLocationMap (Exact name of Registrant as specified in its charter) Nevada 8999 46-0745348 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 153 W. Lake Mead Pkwy |
|
| December 5, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1/A3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 JobLocationMap (Exact name of Registrant as specified in its charter) Nevada 8999 46-0745348 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 153 W. Lake Mead Pkwy |
|
| December 5, 2013 |
November 15, 2013 Maryse Mills-Apenteng Special Counsel Barbara C. Jacobs Assistant Director United States Securities and Exchange Commission Washington, D.C. 20549 Re: JobLocationMap Inc. Amendment No. 3 to Registration Statement on Form S-1 File No. 333-188225 Filed October 4, 2013 Dear Ms. Mills-Apenteng: Below please find the Company’s responses to your comment letter of October 25, 2013. Gene |
|
| October 4, 2013 |
S-1/A 1 jobloc-20131003s1a2.htm JOBLOCATION, S-1/A2 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1/A2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 JobLocationMap (Exact name of Registrant as specified in its charter) Nevada 8999 46-0745348 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. E |
|
| October 4, 2013 |
September 26, 2013 Maryse Mills-Apenteng Special Counsel Barbara C. Jacobs Assistant Director United States Securities and Exchange Commission Washington, D.C. 20549 Re: JobLocationMap Inc. Amendment No. 2 to Registration Statement on Form S-1 File No. 333-188225 Filed August 26, 2013 Dear Ms. Mills-Apenteng: Below please find the Company’s responses to your comment letter of September 23, 2013. G |
|
| October 4, 2013 |
JobLocationMap Subscription Agreement EXHIBIT 99.1: Subscription Agreement JobLocationMap Subscription Agreement 1. Investment: The undersigned (“Buyer”) subscribes for Shares of Common Stock of JobLocationMap at $0.04 per share. Total subscription price ($0.04 times number of Shares): = $. PLEASE MAKE CHECKS PAYABLE TO: JobLocationMap 2. Investor information: Name (type or print) SSN/EIN/Taxpayer I.D. E-Mail address: Address Joint Na |
|
| August 26, 2013 |
June 24, 2013 Maryse Mills-Apenteng Special Counsel Barbara C. Jacobs Assistant Director United States Securities and Exchange Commission Washington, D.C. 20549 Re: JobLocationMap, Inc. Registration Statement on Form S-1 Filed April 30, 2013 File No. 333-188225 Dear Ms. Mills-Apenteng: Below please find the Company’s responses to your comment letter of May 24, 2013. General 1. Since you appear to |
|
| August 26, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 JobLocationMap (Exact name of Registrant as specified in its charter) Nevada 8999 46-0745348 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 153 W. Lake Mead Pkwy |
|
| July 9, 2013 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 JobLocationMap (Exact name of Registrant as specified in its charter) Nevada 8999 46-0745348 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 153 W. Lake Mead Pkwy |
|
| July 9, 2013 |
June 24, 2013 Maryse Mills-Apenteng Special Counsel Barbara C. Jacobs Assistant Director United States Securities and Exchange Commission Washington, D.C. 20549 Re: JobLocationMap, Inc. Registration Statement on Form S-1 Filed April 30, 2013 File No. 333-188225 Dear Ms. Mills-Apenteng: Below please find the Company’s responses to your comment letter of May 24, 2013. General 1. Since you appear to |
|
| April 30, 2013 |
Registration Statement - JOBLOCATION S-1 S-1 1 jobloc04202013-s1.htm JOBLOCATION S-1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 JobLocationMap (Exact name of Registrant as specified in its charter) Nevada 8999 46-0745348 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Ide |
|
| April 30, 2013 |
BYLAWS JOBLOCATIONMAP INC. ARTICLE I. MEETINGS OF SHAREHOLDERS 1.1 Place of Meetings The meetings of shareholders shall be held at such place. either within or without of the state of Nevada, as may be fixed by the Board of Directors. 1.2 Annual Meetings The annual meetings of the shareholders, for the election of Directors and transaction of any other business that may come before the meeting, sh |
|
| April 30, 2013 |
JobLocationMap Subscription Agreement EXHIBIT 99.1: Subscription Agreement JobLocationMap Subscription Agreement 1. Investment: The undersigned (“Buyer”) subscribes for Shares of Common Stock of JobLocationMap at $0.04 per share. Total subscription price ($0.04 times number of Shares): = $. PLEASE MAKE CHECKS PAYABLE TO: JobLocationMap 2. Investor information: Name (type or print) SSN/EIN/Taxpayer I.D. E-Mail address: Address Joint Na |
|
| April 30, 2013 |
EX-3.1 3 exhibit3-1.htm EXHIBIT 3.1 |
